The rise of cochlear gene therapy

Recent evidence provides strong support for the safe and effective use of gene therapy in humans with hearing loss. By means of a single local injection of a set of adeno-associated virus (AAV) vectors, hearing was partially restored in several children with neurosensory nonsyndromic autosomal reces...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Landegger, Lukas D. (VerfasserIn) , Reisinger, Ellen (VerfasserIn) , Lallemend, François (VerfasserIn) , Hage, Steffen R. (VerfasserIn) , Grimm, Dirk (VerfasserIn) , Cederroth, Christopher R. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 4 June 2025
In: Molecular therapy
Year: 2025, Jahrgang: 33, Heft: 6, Pages: 2343-2349
ISSN:1525-0024
DOI:10.1016/j.ymthe.2024.11.012
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.ymthe.2024.11.012
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S1525001624007391
Volltext
Verfasserangaben:Lukas D. Landegger, Ellen Reisinger, François Lallemend, Steffen R. Hage, Dirk Grimm, and Christopher R. Cederroth

MARC

LEADER 00000naa a2200000 c 4500
001 1946044393
003 DE-627
005 20251215110441.0
007 cr uuu---uuuuu
008 251215s2025 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ymthe.2024.11.012  |2 doi 
035 |a (DE-627)1946044393 
035 |a (DE-599)KXP1946044393 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Landegger, Lukas D.  |e VerfasserIn  |0 (DE-588)138437342X  |0 (DE-627)1946046124  |4 aut 
245 1 4 |a The rise of cochlear gene therapy  |c Lukas D. Landegger, Ellen Reisinger, François Lallemend, Steffen R. Hage, Dirk Grimm, and Christopher R. Cederroth 
264 1 |c 4 June 2025 
300 |b Illustrationen 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 8. November 2024, Artikelversion: 4. Juni 2025 
500 |a Gesehen am 15.12.2025 
520 |a Recent evidence provides strong support for the safe and effective use of gene therapy in humans with hearing loss. By means of a single local injection of a set of adeno-associated virus (AAV) vectors, hearing was partially restored in several children with neurosensory nonsyndromic autosomal recessive deafness 9 (DFNB9), harboring variants in the OTOF gene. Current research focuses on refining endoscopic and transmastoid injection procedures to reduce risks of side effects, as emerging evidence suggests bidirectional fluid exchanges between the ear and the brain. Moreover, gene editing approaches and novel AAV capsids are successfully tested in animal models and will likely lead to enhanced targeting of the cochlea. Here, we cover the recent advances in cochlear gene therapy, provide an overview of the translational potential of these new approaches for existing and future clinical trials, and highlight the translational implications that remain to be determined for their application in humans. 
650 4 |a auditory 
650 4 |a cochlea 
650 4 |a CSF 
650 4 |a gene therapy 
650 4 |a hearing loss 
650 4 |a NHP 
650 4 |a off-targeting 
650 4 |a otoferlin 
700 1 |a Reisinger, Ellen  |e VerfasserIn  |4 aut 
700 1 |a Lallemend, François  |e VerfasserIn  |4 aut 
700 1 |a Hage, Steffen R.  |e VerfasserIn  |4 aut 
700 1 |a Grimm, Dirk  |e VerfasserIn  |0 (DE-588)1016476671  |0 (DE-627)70553376X  |0 (DE-576)352260645  |4 aut 
700 1 |a Cederroth, Christopher R.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Molecular therapy  |d Amsterdam : Elsevier, 2000  |g 33(2025), 6 vom: Juni, Seite 2343-2349  |h Online-Ressource  |w (DE-627)320415198  |w (DE-600)2001818-6  |w (DE-576)104344695  |x 1525-0024  |7 nnas  |a The rise of cochlear gene therapy 
773 1 8 |g volume:33  |g year:2025  |g number:6  |g month:06  |g pages:2343-2349  |g extent:7  |a The rise of cochlear gene therapy 
856 4 0 |u https://doi.org/10.1016/j.ymthe.2024.11.012  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S1525001624007391  |x Verlag  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20251215 
993 |a Article 
994 |a 2025 
998 |g 1016476671  |a Grimm, Dirk  |m 1016476671:Grimm, Dirk  |d 910000  |d 911700  |e 910000PG1016476671  |e 911700PG1016476671  |k 0/910000/  |k 1/910000/911700/  |p 5 
999 |a KXP-PPN1946044393  |e 4828033971 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1946044393","title":[{"title":"The rise of cochlear gene therapy","title_sort":"rise of cochlear gene therapy"}],"name":{"displayForm":["Lukas D. Landegger, Ellen Reisinger, François Lallemend, Steffen R. Hage, Dirk Grimm, and Christopher R. Cederroth"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"physDesc":[{"noteIll":"Illustrationen","extent":"7 S."}],"note":["Online verfügbar: 8. November 2024, Artikelversion: 4. Juni 2025","Gesehen am 15.12.2025"],"person":[{"given":"Lukas D.","role":"aut","display":"Landegger, Lukas D.","family":"Landegger","roleDisplay":"VerfasserIn"},{"family":"Reisinger","roleDisplay":"VerfasserIn","given":"Ellen","display":"Reisinger, Ellen","role":"aut"},{"given":"François","display":"Lallemend, François","role":"aut","family":"Lallemend","roleDisplay":"VerfasserIn"},{"family":"Hage","roleDisplay":"VerfasserIn","display":"Hage, Steffen R.","role":"aut","given":"Steffen R."},{"given":"Dirk","display":"Grimm, Dirk","role":"aut","roleDisplay":"VerfasserIn","family":"Grimm"},{"roleDisplay":"VerfasserIn","family":"Cederroth","role":"aut","display":"Cederroth, Christopher R.","given":"Christopher R."}],"origin":[{"dateIssuedDisp":"4 June 2025","dateIssuedKey":"2025"}],"relHost":[{"note":["Gesehen am 28.05.2020"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2001818-6"],"eki":["320415198"],"issn":["1525-0024"]},"origin":[{"dateIssuedDisp":"2000-","dateIssuedKey":"2000","publisher":"Elsevier ; Nature Publ. Group ; Acad. Press","publisherPlace":"Amsterdam ; New York, NY ; Orlando, Fla."}],"title":[{"title":"Molecular therapy","subtitle":"official journal of the American Society of Gene Therapy","title_sort":"Molecular therapy"}],"disp":"The rise of cochlear gene therapyMolecular therapy","recId":"320415198","pubHistory":["1.2000 -"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"corporate":[{"roleDisplay":"Herausgebendes Organ","display":"American Society of Gene Therapy","role":"isb"}],"part":{"year":"2025","text":"33(2025), 6 vom: Juni, Seite 2343-2349","pages":"2343-2349","extent":"7","issue":"6","volume":"33"}}],"id":{"eki":["1946044393"],"doi":["10.1016/j.ymthe.2024.11.012"]}} 
SRT |a LANDEGGERLRISEOFCOCH4202